IE00BM8R0N95
IE00BM8R0N95
Genomics & Biotechnology UCITS ETF
Loading chart...
About this ETF
The Global X Genomics & Biotechnology UCITS ETF seeks to track the Solactive Genomics index. The Solactive Genomics index tracks companies active in the fields of genomics and biotechnology.
TER
0.5%
Total Expense Ratio per year
Fund Size
€59.99M
Assets under management
Holdings
50
Underlying equities
Dividend Yield
0.92%
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
35.27
Weighted Fwd P/E
-105.75
💰 Revenue Estimates
Current Year CY
+13.24% ⌀ 17 Analysts Coverage
Next Year NY
+1,238.55% ⌀ 16 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-1,274.37% ⌀ 13 Analysts Coverage
Next Year NY
+243.44% ⌀ 13 Analysts Coverage
Related ETFs
Fineco AM MarketVector™ Bioproduction Tech & Tools ESG UCITS ETF
148.14 EUR
TER 0.38% 1Y +36%
Fineco AM MarketVector™ Bioproduction Tech & Tools ESG UCITS ETF
14,812.47 EUR
TER 0.38% 1Y +54%
iShares MSCI World Health Care Sector Advanced UCITS ETF
7.23 EUR
TER 0.18%
iShares MSCI World Health Care Sector Advanced UCITS ETF
5.25 EUR
TER 0.18% 1Y +13.8%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
11/02/2021 (4 yrs)
Index Group
Solactive Genomics Index
Solactive Genomics Region
World Country
-
Sector
Health Care Strategy
-
Theme
Biotech Distribution Policy
Accumulating Replication
Full replication Sustainable
No 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
Diversification Score: 17/100 Low (Concentration Risk)
Diversification Score
17/100 Low (Concentration Risk)
5Y Volatility
34.4% p.a.
Max Drawdown (5Y)
-68.9%
Sharpe Ratio (5Y)
-0.21
Beta Factor
1.53
Notes & Warnings
Fund Volume (AUM) Solid fund volume
⚠️ Elevated valuation: Avg P/E of 35.3
🟡 Moderate analyst coverage (13.1 analysts)
⚠️ Elevated top 10 holdings concentration: 50% of fund in top 10 positions.
🔴 Severe sector concentration risk: 100% in "Healthcare".
🔴 Extreme industry concentration: 58% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
🔴 Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.4% p.a.).
⚠️ Historical Stress Test: Maximum peak-to-trough drawdown of -68.9% in the extended horizon.
